Award NoticeActive12481254
SUPPLY of LUTATHERA® (lutetium Lu 177 dotatate) and PLUVICTO™ (lutetium Lu 177 vipivotide tetraxetan)
DEPT OF DEFENSE / DEFENSE HEALTH AGENCY (DHA) / DEFENSE HEALTH AGENCYKey dates?
- Posted?
- Oct 8, 2026
- Response deadline?
- —
- Archive date?
- Oct 15, 2026
- Archive type?
- auto15
Classification?
- Notice type?
- Award Notice
- Base type?
- Award Notice
- Set-aside?
- —
- Set-aside code?
- —
- PSC?
- —
Issuing office?
- Department?
- DEPT OF DEFENSE
- Sub-tier?
- DEFENSE HEALTH AGENCY (DHA)
- Office?
- DEFENSE HEALTH AGENCY
- Office code?
- 097.97DH.HT0014
- Organization type?
- OFFICE
- Office address?
- FALLS CHURCH, VA, 22042, USA
Place of performance?
- Street?
- —
- Street 2?
- —
- City?
- Bethesda
- State?
- Maryland
- Zip?
- 20889
- Country?
- UNITED STATES
Description
The full description is temporarily unavailable (SAM.gov rate limit) and will appear here shortly. View it now on SAM.gov ↗
Award?
- Number?
- HT001426FE141
- Amount?
- $480,119.64
- Date?
- Sep 30, 2026
- Awardee?
- Novartis Pharmaceuticals Corporation
- UEI?
- —
- Awardee address?
- East Hanover, New Jersey, 07936, UNITED STATES
Similar open contracts
Metadata?
- Notice ID?
- b282dc9e8acc4a928ab3a5823a5dd0f3
- Full path?
- DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCY
- Office code?
- 097.97DH.HT0014
- Ingested?
- Oct 9, 2026
- Updated?
- Oct 10, 2026